The emergence of DeepSeek's artificial intelligence models is offering Chinese chipmakers like Huawei a stronger foothold in ...

DeepSeek has shown that China can, in part, sidestep US restrictions on advanced chips by leveraging algorithmic innovations.

Lisata Therapeutics (LSTA) announced preliminary Cohort A data from the ongoing Phase 2 ASCEND trial being conducted at 25 sites across Australia and New Zealand led by the Australasian Gastro ...

PRISM Ascend is our answer to that dilemma. It's about teaching clients to keep building and leveraging on every press win they achieve rather than vanishing after that initial success." ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...